SCIENTURE HOLDINGS, INC. Prepaid Expense and Other Assets, Current
SCIENTURE HOLDINGS, INC. (SCNX) had Prepaid Expense and Other Assets, Current of $775.11 thousand as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2024-11-06
- 2024-09-30: Prepaid Expense and Other Assets, Current $775.11K.
- 2023-12-31: Prepaid Expense and Other Assets, Current $50.72K.
- 2017-03-31: Prepaid Expense and Other Assets, Current -$45.15K.
- 2016-12-31: Prepaid Expense and Other Assets, Current $67.37K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2024-09-30 | $775.11K 10-Q · filed 2024-11-06 |
| 2023-12-31 | $50.72K 10-Q · filed 2024-11-06 |
| 2017-03-31 | -$45.15K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $67.37K 10-K · filed 2017-03-30 |
| 2016-03-31 | -$60.99K 10-Q · filed 2017-05-15 |
| 2015-12-31 | -$44.67K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |